GENERAL COMMENTS
Major concerns 1) The exclusion of people who die during the follow-up bias the results in different ways. First, patients who died are expected to have more previous morbidity and comorbidities and, additionally, the immediate period before death is characterized for a high consumption of resources. Therefore, the exclusion of people who died reduces the amount of medical consumption and their associated costs. Second, if -as postulated by the authors-obesity is associated with morbidity, we can expect more deaths among obese than in nonobese people. Therefore, the exclusion of patients who die will bias the results reducing the costs of obese people in a higher proportion.
2) The authors state in the protocol "Overweight and obesity is assessed annually for each patient". This is an unrealistic assumption in a retrospective study based on electronic medical records (It is unbelievable that physicians assess the weight of all adults every year). On the contrary, it is more likely that physicians assess obesity in patients at higher risk (diabetics, cardiac patients, hypertensive patients, and so on). In this sense, we can expect a strong association between these diseases (and their costs) and obesity, but not because obesity is their cause, but because it has been registered only when these conditions are present.
3) The authors note also in the protocol "data retrieved from the population census will allow us to consider other socioeconomic information, such as the distance from the current place of residence to the healthcare centre, educational level, marital status and the presence of duplicate medical coverage". To my knowledge, there is no way in Spain to combine census data with other records (at individual level). It would be possible to obtain aggregated census data by neighborhood or even by census units (blocks of various contiguous buildings), but this would require other types of statistical analysis (multilevel models).
4) It seems that "the measures for the utilization of healthcare resources analysed in this study are … defined over a one-year period". Thus, authors seem to transform follow-up data (costs of each person from 2003 until the end of the follow-up period or the censure of the case), in panel data (one cross-section cut by year). The planned analysis confirms this design. From my point of view, this analysis (acceptable to repeated annual surveys) is inadequate when it is possible to follow-up individual patients throughout all the period.
5) The discussion does not discuss the authentic strengths of the study (population data, low cost based in electronic medical records, long follow-up), nor the limitations (information biases related with retrospective observational data) Minor Essential Revisions 6) Page 1, line 6. Title. The study does not aim to evaluate the "comorbidity impact". I suggest not to include these words in the title. 7) Page 2, lines 9-14. Abstract-Background. The sentence anounce two objectives, but there is only one. 8) Page 2, line 26. Methods/design. I am not sure what are "rate ratios" in this context. This is a typical measure of cohort studies but not in panel data. 9) Page 3, line 23-28. Key messages. The message about clinical trials is not related with the results of the project. 10) Page 3, line 30-32. Key messages. This key message would be a conclusion (or not) of the finished project. But not is a message of the actual paper. 11) Page 3, line 37-44. Strengths and limitations. These arguments are not strengths of the study. 12) Page 3, line 37-44. Strengths and limitations. What bias is related with the selection of therapeutic groups? This issue is not tackled in the protocol. 13) Page 4, line 21-24. Introduction. Revise words as "cholesterol" (vs dyslipidemia), gallblader disease and biliari calculi. 14) Page 5, line 11-23. Objectives. The first objective is defined as "assess the magnitude of the incremental use of healthcare resources and their associated costs for a population of adult overweight and obese patients… " and the second is defined as "to explore the impact of overweight and obesity on the increased consumption of resources". If the first objective is about "incremental" costs (incremental respect nonobese people?), both objectives are very similar. 15) Page 5, line 29. Study design and population. The term "postauthorization" for defining the study design have no sense in this project (it is not a drug or device post-authorization study). 16) Page 10, Author contributions. They should be referred to the actual paper, not for the future papers with the study results. 17) Page 10-13. Bibliography. Please, homogeneize the references according to the Journal norms.
Discretionary revisions 18) Page 1, line 6. Title. The word "Spain" in the article title suggests a national study, while the study setting is limited to a relatively reduced territory located near Barcelona. I suggest changing the title for "… associated with obesity in Badalona, Spain".
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THE STUDY
First, I would like to thank you for the opportunity to revise this protocol submitted to the BMJ Open.
The manuscript has several major issues to deal with:
• Inaccuracy in the redaction of the abstract and in the Strengths and Limitation of the study section.
• Inaccuracy in the scientific epidemiology terms used. The words "observational trials" is an oxymoron.
• Inexistence of the calculation of the statistical power.
• Inaccuracy in some of the references used in the Background section. There are in the literature references more appropriate to be used.
• Lack of clarification in the Methods/designs. Section that needs to be accurate in a study protocol. As examples: o Authors will exclude those patients who died during the study and there is not clear if patients will be followed-up during the study (it seems to me the inexistence of an individual follow-up).
However, authors will be use standard survival analyses as it is written in the abstract of the manuscript. o Authors did not explain how they will assess annually the body mass index of each patient. Are they going to cite each patient annually?
• The data is not representative of the Spanish population.
• Lack of paying attention to the major potential confounding factors. Those overweight/obese patients probably they have other risk factors that increase the use of resource utilization and medical treatments such us smoking or following specific dietary patterns including alcohol intake.
• The authors have not followed the guidelines for reporting economic evaluations (ie. Siegel et al. JAMA 1996; 276:1339-41 ).
All these major issues and other minor points as well, from my point of view, preclude paying further attention to this manuscript and in any case, all these points need to be address before being acceptable to be published in a major revision.
GENERAL COMMENTS
VERSION 1 -AUTHOR RESPONSE
The manuscript was declined publication and the author informed about the reviewers' comments. The authors then re-submitted a heavily revised version which was accepted. There is no author's response. Competing interest: none.
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THE STUDY
There are (minor) some typographical errors.
RESULTS & CONCLUSIONS
Because the paper is a study protocol strictly speaking there are still no results.
GENERAL COMMENTS
The authors have responded adequately (and, if necessary, modified the manuscript) to all issues raised in the previous review. I have not further comments or suggestions.
